LYMPHOSCINTIGRAPHY WITH I-123 LABELED EPIDERMAL GROWTH-FACTOR

被引：34
|
作者：
SCHATTEN, C
PATEISKY, N
VAVRA, N
EHRENBOCK, P
ANGELBERGER, P
SIVOLAPENKO, G
EPENETOS, A
机构：
[1] HAMMERSMITH HOSP,IMPERIAL CANC RES FUND,ONCOL GRP,LONDON W12 0HS,ENGLAND
[2] UNIV VIENNA,DEPT OBSTET & GYNAECOL 1,A-1010 VIENNA,AUSTRIA
[3] AUSTRIAN RES CTR,DEPT RADIOPHARM,SEIBERSDORF,AUSTRIA
来源：
LANCET | 1991年 / 337卷 / 8738期
关键词：
D O I：
10.1016/0140-6736(91)91169-U
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We have used I-123-labelled epidermal growth factor (EGF) scans to study 14 patients with advanced cervical cancer. Abnormal lymph node imaging was seen most clearly 6-8 h after the injection and revealed abnormal uptake by pelvic lymph nodes in 11 patients. 4 of these 11 had abnormal computerised tomographic and ultrasound scans; in the other 7 conventional radiology did not confirm the presence of disease.
引用
收藏
页码：395 / 396
页数：2
相关论文
共 50 条
12345